BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27838151)

  • 1. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
    Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
    Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
    Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
    Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
    Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
    Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
    Worden FP; Moyer J; Lee JS; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Hogikyan N; Lassig AA; Emerick K; Mukherji S; Hadjiski L; Tsien CI; Miller TH; Wallace NE; Mason HL; Bradford CR; Wolf GT
    Laryngoscope; 2009 Aug; 119(8):1510-7. PubMed ID: 19504552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
    Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
    Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
    Basheeth N; O'Leary G; Sheahan P
    JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
    Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
    Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngeal recurrence sites in patients previously treated with transoral laser microsurgery for squamous cell carcinoma.
    Horwich P; Rigby MH; MacKay C; Melong J; Williams B; Bullock M; Hart R; Trites J; Taylor SM
    J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):14. PubMed ID: 29433567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer.
    Tennant PA; Cash E; Bumpous JM; Potts KL
    Head Neck; 2014 Nov; 36(11):1628-33. PubMed ID: 24115178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: Retrospective analysis of 199 cases.
    Weiss BG; Bertlich M; Canis M; Ihler F
    Head Neck; 2017 Jun; 39(6):1166-1176. PubMed ID: 28252821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
    Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
    Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases.
    Bussu F; Miccichè F; Rigante M; Dinapoli N; Parrilla C; Bonomo P; Cadoni G; Mantini G; Galli J; Rufini V; Almadori G; Valentini V; Paludetti G
    Head Neck; 2012 Apr; 34(4):573-9. PubMed ID: 21692130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment, comorbidity and survival in stage III laryngeal cancer.
    Connor KL; Pattle S; Kerr GR; Junor E
    Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure.
    Li M; Lorenz RR; Khan MJ; Burkey BB; Adelstein DJ; Greskovich JF; Koyfman SA; Scharpf J
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):245-51. PubMed ID: 23585149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.